Sign up for free insights newsletter
20

Saudi Pharmaceutical Industries

2070TADAWUL

Need professional-grade analysis? Visit stockanalysis.com

SAR 28.88
-1.50%
End of day
Market Cap

$3.30B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.450.79-0.190.27-0.270.13
Calmar1.191.08-0.210.33-0.090.31
Sharpe0.240.46-0.120.18-0.170.07
Omega1.101.111.001.061.001.05
Martin2.402.62-0.440.69-0.130.72
Ulcer4.866.969.178.9145.6617.90

Saudi Pharmaceutical Industries (2070) Price Performance

Saudi Pharmaceutical Industries (2070) trades on TADAWUL in SAR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at SAR28.88, down 1.50% from the previous close.

Over the past year, 2070 has traded between a low of SAR22.56 and a high of SAR31.04. The stock has gained 11.5% over this period. It is currently 7.0% below its 52-week high.

Saudi Pharmaceutical Industries has a market capitalization of $3.30B.

About Saudi Pharmaceutical Industries

Saudi Pharmaceutical Industries (2070) is a leading pharmaceutical company based in Saudi Arabia that develops, manufactures, and commercializes a diverse range of pharmaceutical products, including tablets, capsules, suspensions, injections, creams, and antiseptic products. The company is primarily engaged in the manufacturing, wholesale, and retail of medicines and related medical products, as well as research and development activities in the medical and pharmaceutical fields.

Company Info

Exchange
TADAWUL
Currency
SAR

Financial Metrics

Revenue (TTM)
N/A
EBITDA
N/A
Profit Margin
N/A
EPS (TTM)
N/A
Book Value
N/A

Technical Indicators

52 Week High
SAR 31.66
52 Week Low
SAR 20.94
50 Day MA
SAR 28.04
200 Day MA
SAR 27.41
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
N/A
Price/Book
N/A
Enterprise Value
$3.30B